{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:57:07Z","timestamp":1794581827491,"version":"4.9.1"},"reference-count":265,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.18492"],"award-info":[{"award-number":["320.6750.18492"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019B030302012"],"award-info":[{"award-number":["2019B030302012"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2022J236"],"award-info":[{"award-number":["2022J236"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YFG0137"],"award-info":[{"award-number":["2021YFG0137"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003851","name":"Department of Education, Heilongjiang Province","doi-asserted-by":"publisher","award":["SJGY20200447"],"award-info":[{"award-number":["SJGY20200447"]}],"id":[{"id":"10.13039\/501100003851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81821002"],"award-info":[{"award-number":["81821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.redox.2023.102754","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:33:45Z","timestamp":1684413225000},"page":"102754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":248,"special_numbering":"C","title":["Drug-induced oxidative stress in cancer treatments: Angel or devil?"],"prefix":"10.1016","volume":"63","author":[{"given":"Hao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionghua","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaijun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102754_bib1","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1002\/mco2.127","article-title":"Redox signaling at the crossroads of human health and disease","author":"Zuo","year":"2022","journal-title":"Medcomm"},{"key":"10.1016\/j.redox.2023.102754_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","article-title":"Oxidative stress: a concept in redox biology and medicine","volume":"4","author":"Sies","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib3","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2023.102754_bib4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","article-title":"The complex interplay between antioxidants and ROS in cancer","volume":"30","author":"Harris","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.redox.2023.102754_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2023.102754_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41568-019-0135-7","article-title":"Targeting cancer vulnerabilities with high-dose vitamin C","volume":"19","author":"Ngo","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cell.2019.06.005","article-title":"BACH1 stabilization by antioxidants stimulates lung cancer metastasis","volume":"178","author":"Wiel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.redox.2023.102754_bib8","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1001\/jama.2022.8970","article-title":"Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US preventive services task force recommendation statement","volume":"327","author":"Mangione","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2023.102754_bib9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.redox.2023.102754_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-022-01320-5","article-title":"Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies","volume":"15","author":"Tian","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib12","article-title":"Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells","volume":"128","author":"Rawat","year":"2020","journal-title":"Biomed. Pharmacother. Biomed. pharmacotherapie"},{"key":"10.1016\/j.redox.2023.102754_bib13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1186\/s12885-019-6438-y","article-title":"ROS as a novel indicator to predict anticancer drug efficacy","volume":"19","author":"Zaidieh","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41419-020-2488-y","article-title":"Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2023.102754_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.102754_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: new insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.redox.2023.102754_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2023.102754_bib18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2023.102754_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-019-0518-9","article-title":"Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity","volume":"26","author":"Volarevic","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2023.102754_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23113016","article-title":"Improving the phototherapeutic efficiencies of molecular and nanoscale materials by targeting mitochondria","volume":"23","author":"Lin","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2023.102754_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.redox.2016.01.010","article-title":"Redox homeostasis: the Golden Mean of healthy living","volume":"8","author":"Ursini","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.redox.2023.102754_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of vascular nitric oxide and reactive oxygen species and their regulation","volume":"99","author":"Tejero","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib27","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1093\/jxb\/erz067","article-title":"Considerations of the importance of redox state for reactive nitrogen species action","volume":"70","author":"Hancock","year":"2019","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.redox.2023.102754_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jxb\/eraa331","article-title":"Nitric oxide, other reactive signalling compounds, redox, and reductive stress","volume":"72","author":"Hancock","year":"2021","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.redox.2023.102754_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2023.102754_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","article-title":"Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology","volume":"23","author":"Sies","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2023.102754_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10549-020-05762-8","article-title":"Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study","volume":"183","author":"Khalefa","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.redox.2023.102754_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ejmech.2019.06.010","article-title":"Medicinal prospects of antioxidants: a review","volume":"178","author":"Neha","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","article-title":"Tumor suppressors and cell metabolism: a recipe for cancer growth","volume":"23","author":"Jones","year":"2009","journal-title":"Gene Dev."},{"key":"10.1016\/j.redox.2023.102754_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achille\u2019' heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib35","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.redox.2023.102754_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2023.01.012","article-title":"NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer","volume":"35","author":"Weiss-Sadan","year":"2023","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2023.102754_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102308","article-title":"Cancer metabolism: phenotype, signaling and therapeutic targets","volume":"9","author":"Park","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.redox.2023.102754_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41419-022-05108-w","article-title":"SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer","volume":"13","author":"Ding","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2023.102754_bib39","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.celrep.2016.11.019","article-title":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer","volume":"17","author":"Mani","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2023.102754_bib40","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.121.056929","article-title":"MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction","volume":"145","author":"Song","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2023.102754_bib41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem. : Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib42","doi-asserted-by":"crossref","first-page":"Jc110","DOI":"10.7326\/J22-0078","article-title":"USPSTF recommends against beta carotene or vitamin E supplements for preventing CVD or cancer in adults","volume":"175","author":"Tanner","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.redox.2023.102754_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12916-022-02366-5","article-title":"Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study","volume":"20","author":"Xin","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.redox.2023.102754_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12916-021-02041-1","article-title":"Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study","volume":"19","author":"Fu","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.redox.2023.102754_bib45","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2023.102754_bib46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2023.102754_bib47","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2023.102754_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: progress and perspectives","volume":"15","author":"Martins-Teixeira","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.redox.2023.102754_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in doxorubicin-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.redox.2023.102754_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.redox.2015.06.014","article-title":"The redox biology network in cancer pathophysiology and therapeutics","volume":"5","author":"Manda","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semcancer.2018.08.010","article-title":"Oxidative stress-modulating drugs have preferential anticancer effects\u2013- involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration","volume":"58","author":"Tang","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.redox.2023.102754_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2023.102754_bib53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2009.04.043","article-title":"Peroxiredoxins, a novel target in cancer radiotherapy","volume":"286","author":"Zhang","year":"2009","journal-title":"Cancer lett."},{"key":"10.1016\/j.redox.2023.102754_bib54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1476-4598-12-138","article-title":"Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer","volume":"12","author":"Verschoor","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib55","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.trecan.2020.04.009","article-title":"Mitochondrial stress response and cancer","volume":"6","author":"O'Malley","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib56","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.7150\/ijbs.59404","article-title":"Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells","volume":"17","author":"Wei","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.redox.2023.102754_bib58","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1007\/s11033-022-07192-9","article-title":"Romidepsin and tamoxifen cooperatively induce senescence of pancreatic cancer cells through downregulation of FOXM1 expression and induction of reactive oxygen species\/lipid peroxidation","volume":"49","author":"Okuni","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib59","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib60","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2023.102754_bib61","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2023.102754_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13063-019-3963-6","volume":"21","author":"Carrasco","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.redox.2023.102754_bib63","unstructured":"Li, Y., Wang, J., Zhang, Y., Zhang, L., An, T., Ding, Y., Anthracycline-induced oxidative stress mediates cardiotoxicity via perturbation of ATP homeostasis and ER stress. Redox Biol., 36, 101661.."},{"key":"10.1016\/j.redox.2023.102754_bib64","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2023.102754_bib65","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy\u2013- an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1756-8722-3-28","article-title":"Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells","volume":"3","author":"Yedjou","year":"2010","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib67","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/CM9.0000000000001628","article-title":"Oxidative stress in leukemia and antioxidant treatment","volume":"134","author":"Dong","year":"2021","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.redox.2023.102754_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1756-9966-33-42","article-title":"Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells","volume":"33","author":"Kumar","year":"2014","journal-title":"J. Exp. Clin. Cancer Res. : CRN"},{"key":"10.1016\/j.redox.2023.102754_bib69","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-03357-1","article-title":"Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT\/mTOR pathway","volume":"12","author":"Fang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2023.102754_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","article-title":"Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis","volume":"20","author":"Chen","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.redox.2023.102754_bib71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-017-0424-0","article-title":"Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1","volume":"10","author":"Ling","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib72","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114903","article-title":"Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy","volume":"14","author":"Zhang","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2023.102754_bib74","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.1806296115","article-title":"Elesclomol restores mitochondrial function in genetic models of copper deficiency","volume":"115","author":"Soma","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2023.102754_bib75","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1038\/s41388-022-02364-0","article-title":"Copper ionophore elesclomol selectively targets GNAQ\/11-mutant uveal melanoma","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2023.102754_bib76","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-15-2887","article-title":"Ivermectin induces cytostatic autophagy by blocking the PAK1\/akt Axis in breast cancer","volume":"76","author":"Dou","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib77","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1080\/15548627.2016.1231494","article-title":"Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer","volume":"12","author":"Wang","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2023.102754_bib78","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1039\/D2CS00673A","article-title":"The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy","volume":"52","author":"Han","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib79","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1039\/C9CS00648F","article-title":"Multifunctional sonosensitizers in sonodynamic cancer therapy","volume":"49","author":"Son","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib80","series-title":"2D Nano-Sonosensitizers Facilitate Energy Transfer to Enhance Sonodynamic Therapy. Advanced Materials","author":"Lin","year":"2023"},{"key":"10.1016\/j.redox.2023.102754_bib81","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1039\/D1CS00403D","article-title":"Advanced biotechnology-assisted precise sonodynamic therapy","volume":"50","author":"Zhang","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib82","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","article-title":"Redox regulation of immunometabolism","volume":"21","author":"Muri","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.redox.2023.102754_bib83","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/ars.2016.6633","article-title":"Clinically evaluated cancer drugs inhibiting redox signaling","volume":"26","author":"Kirkpatrick","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib84","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.redox.2023.102754_bib85","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1039\/D0CS00718H","article-title":"Engineering nanomedicine for glutathione depletion-augmented cancer therapy","volume":"50","author":"Xiong","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib86","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41422-019-0162-7","article-title":"Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy","volume":"29","author":"Mugoni","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2023.102754_bib87","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2019.07.009","article-title":"MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells","volume":"168","author":"Gana","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9584932","article-title":"Oxidation resistance of the sulfur amino acids: methionine and cysteine","volume":"2017","author":"Bin","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.redox.2023.102754_bib89","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1096\/fj.201701157R","article-title":"Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells","volume":"32","author":"Miran","year":"2018","journal-title":"Faseb. J. : Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.redox.2023.102754_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030517","article-title":"Disulfiram acts as a potent radio-chemo sensitizer in head and neck squamous cell carcinoma cell lines and transplanted xenografts","volume":"10","author":"Yao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.redox.2023.102754_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105854","article-title":"Thioredoxin reductase as a pharmacological target","volume":"174","author":"Bj\u00f8rklund","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2023.102754_bib92","doi-asserted-by":"crossref","first-page":"7309","DOI":"10.1021\/acs.jmedchem.8b01595","article-title":"Targeting the thioredoxin system as a strategy for cancer therapy","volume":"62","author":"Bian","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-pharmtox-052220-102509","article-title":"Thioredoxin reductase inhibition for cancer therapy","volume":"62","author":"Gencheva","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2023.102754_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105854","article-title":"Thioredoxin reductase as a pharmacological target","volume":"174","author":"Bj\u00f8rklund","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2023.102754_bib95","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","article-title":"Targeting the thioredoxin system for cancer therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib96","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.21873\/anticanres.15420","article-title":"The thioredoxin-1 inhibitor, PX-12, suppresses local osteosarcoma progression","volume":"41","author":"Kinoshita","year":"2021","journal-title":"Anticancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib97","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41416-022-01835-1","article-title":"TXN inhibitor impedes radioresistance of colorectal cancer cells with decreased ALDH1L2 expression via TXN\/NF-\u03baB signaling pathway","volume":"127","author":"Yu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib98","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41423-022-00858-1","article-title":"NADPH oxidase family proteins: signaling dynamics to disease management","volume":"19","author":"Begum","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.redox.2023.102754_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165207","article-title":"Anti-cancer effects of auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels","volume":"27","author":"Cui","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2023.102754_bib101","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discover. Oncology"},{"key":"10.1016\/j.redox.2023.102754_bib102","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/1078-0432.CCR-18-2751","article-title":"Auranofin protects intestine against radiation injury by modulating p53\/p21 pathway and radiosensitizes human colon tumor","volume":"25","author":"Nag","year":"2019","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib104","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/vco.12533","article-title":"Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma","volume":"18","author":"Endo-Munoz","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.copbio.2021.03.001","article-title":"Glutathione and its precursors in cancer","volume":"68","author":"Asantewaa","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.redox.2023.102754_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11081624","article-title":"Plant glutathione peroxidases: non-heme peroxidases with large functional flexibility as a core component of ROS-processing mechanisms and signalling","volume":"11","author":"Bela","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102754_bib107","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tibs.2006.11.003","article-title":"Mammalian catalase: a venerable enzyme with new mysteries","volume":"32","author":"Kirkman","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070955","article-title":"Metabolic regulation of redox balance in cancer","volume":"11","author":"Purohit","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2023.102754_bib109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.freeradbiomed.2017.07.018","article-title":"Control of the NADPH supply for oxidative stress handling in cancer cells","volume":"112","author":"Moreno-S\u00e1nchez","year":"2017","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib110","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1158\/1078-0432.CCR-16-1129","article-title":"NAD+ kinase as a therapeutic target in cancer","volume":"22","author":"Tedeschi","year":"2016","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib111","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/mol.114.096727","article-title":"Suppression of cytosolic NADPH pool by thionicotinamide increases oxidative stress and synergizes with chemotherapy","volume":"88","author":"Tedeschi","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/ars.2005.7.385","article-title":"Molecular mechanisms activating the Nrf2-Keap 1 pathway of antioxidant gene regulation","volume":"7","author":"Kobayashi","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2023.102754_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102312","article-title":"Hypoxia-induced HIF-1\u03b1\/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer","volume":"52","author":"Lin","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib115","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s12272-011-1021-3","article-title":"A novel approach to cancer therapy using PX-478 as a HIF-1\u03b1 inhibitor","volume":"34","author":"Lee","year":"2011","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.redox.2023.102754_bib116","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1002\/cam4.5311","article-title":"The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells","volume":"12","author":"Ji","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.redox.2023.102754_bib117","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1039\/C9NP00061E","article-title":"The role of natural products in revealing NRF2 function","volume":"37","author":"Zhang","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib118","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1007\/s00018-021-03925-4","article-title":"Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNF\u03b1","volume":"78","author":"Rummel","year":"2021","journal-title":"Cell. Mol. Life Sci. : CM"},{"key":"10.1016\/j.redox.2023.102754_bib119","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919840098","article-title":"Peripheral and central oxidative stress in chemotherapy-induced neuropathic pain","volume":"15","author":"Shim","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.redox.2023.102754_bib120","article-title":"Ocular adverse effects of anti-cancer chemotherapy","volume":"1","author":"Singh","year":"2012","journal-title":"J. Cancer Therapeut. Res."},{"key":"10.1016\/j.redox.2023.102754_bib121","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3892\/ol.2013.1768","article-title":"Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells","volume":"7","author":"Shirato","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.redox.2023.102754_bib122","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41417-022-00501-1","article-title":"Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4","volume":"29","author":"Hu","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.redox.2023.102754_bib123","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41598-020-58871-1","article-title":"Nandrolone induces a stem cell-like phenotype in human hepatocarcinoma-derived cell line inhibiting mitochondrial respiratory activity","volume":"10","author":"Agriesti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib150","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.redox.2023.102754_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105575","article-title":"Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance","volume":"167","author":"Mirzaei","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2023.102754_bib157","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.redox.2018.09.020","article-title":"Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease","volume":"20","author":"Mapuskar","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109149","article-title":"Quercetin supplementation attenuates cisplatin induced myelosuppression in mice through regulation of hematopoietic growth factors and hematopoietic inhibitory factors","volume":"110","author":"Chuang","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.redox.2023.102754_bib172","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejphar.2018.12.014","article-title":"Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents","volume":"843","author":"Atiq","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib166","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/ars.2016.6665","article-title":"Oxidant mechanisms in renal injury and disease","volume":"25","author":"Ratliff","year":"2016","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ctrv.2017.11.009","article-title":"Management of QT prolongation induced by anti-cancer drugs: target therapy and old agents. Different algorithms for different drugs","volume":"63","author":"Coppola","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.redox.2023.102754_bib176","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/17425255.2017.1277205","article-title":"The mechanisms of cyclophosphamide-induced testicular toxicity and the protective agents","volume":"13","author":"Ghobadi","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.redox.2023.102754_bib177","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2261-11-62","article-title":"Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice","volume":"11","author":"Yousif","year":"2011","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.redox.2023.102754_bib178","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10549-021-06280-x","article-title":"Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies","volume":"188","author":"Dempsey","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.redox.2023.102754_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/toxics9100229","article-title":"Pathomechanisms of paclitaxel-induced peripheral neuropathy","volume":"9","author":"Klein","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.redox.2023.102754_bib125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2023.102754_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117173","article-title":"The role of melatonin on doxorubicin-induced cardiotoxicity: a systematic review","volume":"241","author":"Najafi","year":"2020","journal-title":"Life Sci."},{"issue":"Suppl 1","key":"10.1016\/j.redox.2023.102754_bib127","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.thromres.2021.12.017","article-title":"Cardiovascular toxic effects of antitumor agents: pathogenetic mechanisms","volume":"213","author":"Pantazi","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.redox.2023.102754_bib128","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1111\/bph.13643","article-title":"Trastuzumab cardiotoxicity: from clinical trials to experimental studies","volume":"174","author":"Nemeth","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib129","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/0929867324666170407125017","article-title":"Immune checkpoint inhibitors and cardiac toxicity: an emerging issue","volume":"25","author":"Varricchi","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10741-020-10063-9","article-title":"Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets","volume":"26","author":"Fabiani","year":"2021","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib131","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","article-title":"Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?","volume":"18","author":"Levis","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib132","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yjmcc.2013.11.007","article-title":"Cardiomyocyte autophagy and cancer chemotherapy","volume":"71","author":"Li","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.redox.2023.102754_bib133","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","article-title":"Metabolic aspects of anthracycline cardiotoxicity","volume":"22","author":"Russo","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib134","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib135","doi-asserted-by":"crossref","first-page":"C489","DOI":"10.1152\/ajpcell.00152.2021","article-title":"Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes","volume":"321","author":"Ali Pour","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.redox.2023.102754_bib136","article-title":"Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis","volume":"258","author":"Mounier","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2023.102754_bib137","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012075","article-title":"Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases","volume":"12","author":"Nguyen","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib138","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2023.102754_bib139","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1474-4422(13)70087-5","article-title":"Trying to unravel the mysteries of chemobrain","volume":"12","author":"Holmes","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2023.102754_bib140","volume":"9","author":"McElroy","year":"2020"},{"key":"10.1016\/j.redox.2023.102754_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.12.029","volume":"134","author":"Ren","year":"2019","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib142","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1089\/ars.2011.3923","article-title":"Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases","volume":"15","author":"Lehner","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111695","article-title":"The blood-brain barrier, oxidative stress, and insulin resistance","volume":"10","author":"Banks","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102754_bib144","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.freeradbiomed.2011.03.009","article-title":"2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-\u03b1 release: implications for the reactive oxygen species-mediated mechanisms of chemobrain","volume":"50","author":"Aluise","year":"2011","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cbi.2015.02.021","article-title":"Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: role of NF\u03baB\/MAPK pathway","volume":"231","author":"Nafees","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2023.102754_bib146","doi-asserted-by":"crossref","first-page":"30324","DOI":"10.18632\/oncotarget.25718","article-title":"Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\"chemobrain\")","volume":"9","author":"Keeney","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2023.102754_bib147","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/thno.67410","article-title":"HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity","volume":"12","author":"McAlpin","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2023.102754_bib148","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/0008-5472.CAN-16-1817","article-title":"Pifithrin-\u03bc prevents cisplatin-induced chemobrain by preserving neuronal mitochondrial function","volume":"77","author":"Chiu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib149","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.redox.2023.102754_bib151","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib152","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2023.102754_bib153","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000070","article-title":"Mechanisms of drug-induced liver injury","volume":"14","author":"Stephens","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.redox.2023.102754_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051018","article-title":"Drug-induced liver injury: cascade of events leading to cell death, apoptosis or necrosis","volume":"18","author":"Iorga","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.563750","article-title":"Licorice ameliorates cisplatin-induced hepatotoxicity through antiapoptosis, antioxidative stress, anti-inflammation, and acceleration of metabolism","volume":"11","author":"Man","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103483","article-title":"Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers","volume":"21","author":"Ko\u017ami\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib159","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7942531","article-title":"Antifibrotic effect of lactulose on a methotrexate-induced liver injury model","volume":"2017","author":"Taskin","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.redox.2023.102754_bib160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/toxsci\/kfw169","article-title":"Editor's highlight: modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues","volume":"154","author":"Norona","year":"2016","journal-title":"Toxicol. Sci. : Off. J. Soc. Toxicol."},{"key":"10.1016\/j.redox.2023.102754_bib161","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s40199-019-00309-9","article-title":"Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the I\u0138B\u03b1\/NF\u0138B in rats","volume":"27","author":"Ebrahimi","year":"2019","journal-title":"Daru : J. Fac. Pharm. Tehran Univ. Med. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib162","doi-asserted-by":"crossref","first-page":"20725","DOI":"10.1007\/s11356-020-08557-y","article-title":"Chicoric acid prevents methotrexate hepatotoxicity via attenuation of oxidative stress and inflammation and up-regulation of PPAR\u03b3 and Nrf2\/HO-1 signaling","volume":"27","author":"Hussein","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.redox.2023.102754_bib163","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1007\/s11356-019-07532-6","article-title":"Ferulic acid prevents oxidative stress, inflammation, and liver injury via upregulation of Nrf2\/HO-1 signaling in methotrexate-induced rats","volume":"27","author":"Mahmoud","year":"2020","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.redox.2023.102754_bib164","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ackd.2019.08.005","article-title":"Nephrotoxic chemotherapy agents: old and new","volume":"27","author":"Nicolaysen","year":"2020","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.redox.2023.102754_bib165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.redox.2023.102754_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082951","article-title":"Roles of Nrf2 in protecting the kidney from oxidative damage","volume":"21","author":"Nezu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib169","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08820139.2012.732166","article-title":"Protection against cyclophosphamide-induced myelosuppression by ZPDC glycoprotein (24 kDa)","volume":"42","author":"Lee","year":"2013","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.redox.2023.102754_bib170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib171","article-title":"Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo","volume":"143","author":"Zhu","year":"2021","journal-title":"Biomed. Pharmacother. Biomed. pharmacotherapie"},{"key":"10.1016\/j.redox.2023.102754_bib173","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress","volume":"15","author":"Gilliam","year":"2011","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib174","doi-asserted-by":"crossref","first-page":"15833","DOI":"10.18632\/aging.203203","article-title":"The lack of functional DNMT2\/TRDMT1 gene modulates cancer cell responses during drug-induced senescence","volume":"13","author":"Bloniarz","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.redox.2023.102754_bib175","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamadermatol.2021.3676","article-title":"Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors","volume":"157","author":"Bhoyrul","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.redox.2023.102754_bib180","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7150\/ijbs.30488","article-title":"BMI1 deficiency results in female infertility by activating p16\/p19 signaling and increasing oxidative stress","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib181","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8159","article-title":"Role of reactive oxygen species in tumors based on the 'seed and soil' theory: a complex interaction (Review)","volume":"46","author":"Liang","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib182","article-title":"Emerging role of NRF2 in ROS-mediated tumor chemoresistance","volume":"131","author":"Xue","year":"2020","journal-title":"Biomed. Pharmacother. Biomed. pharmacotherapie"},{"key":"10.1016\/j.redox.2023.102754_bib183","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/acs.chemrestox.5b00485","article-title":"Covalent modification of CDK2 by 4-hydroxynonenal as a mechanism of inhibition of cell cycle progression","volume":"29","author":"Camarillo","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2023.102754_bib184","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/pbi.12659","article-title":"The heat-shock protein\/chaperone network and multiple stress resistance","volume":"15","author":"Jacob","year":"2017","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.redox.2023.102754_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","article-title":"Modulating ROS to overcome multidrug resistance in cancer","volume":"41","author":"Cui","year":"2018","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anti Cancer Chemother."},{"key":"10.1016\/j.redox.2023.102754_bib186","article-title":"Targeting reactive oxygen species capacity of tumor cells with repurposed drug as an anticancer therapy","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2023.102754_bib187","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2174\/0929867321666140601164647","article-title":"Oxidative stress, redox signaling and cancer chemoresistance: putting together the pieces of the puzzle","volume":"21","author":"Victorino","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8120603","article-title":"Metabolic remodelling: an accomplice for new therapeutic strategies to fight lung cancer","volume":"8","author":"Mendes","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102754_bib189","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1089\/ars.2009.2692","article-title":"Adaptation to oxidative stress, chemoresistance, and cell survival","volume":"11","author":"Landriscina","year":"2009","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10070289","article-title":"Metabolic reprogramming of chemoresistant cancer cells and the potential significance of metabolic regulation in the reversal of cancer chemoresistance","volume":"10","author":"Chen","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.redox.2023.102754_bib191","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. : CRN"},{"key":"10.1016\/j.redox.2023.102754_bib192","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082774","article-title":"Non-coding RNAs in lung tumor initiation and progression","volume":"21","author":"Santos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib193","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the hallmarks of cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2023.102754_bib194","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.taap.2018.09.014","article-title":"Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2\/Nrf2 and mitochondria","volume":"359","author":"Ryoo","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1089\/ars.2017.7440","article-title":"Dl-3-n-Butylphthalide inhibits NLRP3 inflammasome and mitigates alzheimer's-like pathology via nrf2-TXNIP-TrX Axis","volume":"30","author":"Wang","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102754_bib196","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/pcmr.12946","article-title":"NRF2-dependent stress defense in tumor antioxidant control and immune evasion","volume":"34","author":"Friedmann Angeli","year":"2021","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.redox.2023.102754_bib197","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.18632\/aging.103777","article-title":"Metformin suppresses Nrf2-mediated chemoresistance in hepatocellular carcinoma cells by increasing glycolysis","volume":"12","author":"Cai","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.redox.2023.102754_bib198","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1535-7163.MCT-21-0210","article-title":"A novel Nrf2 pathway inhibitor sensitizes keap 1-mutant lung cancer cells to chemotherapy","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.redox.2023.102754_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197216","article-title":"NRF2 and PPAR-\u03b3 pathways in oligodendrocyte progenitors: focus on ROS protection, mitochondrial biogenesis and promotion of cell differentiation","volume":"21","author":"De Nuccio","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102754_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153414","article-title":"Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-\u03baB-Nrf2 signaling in colorectal cancer cell","volume":"82","author":"Wang","year":"2021","journal-title":"Phytomedicine : Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.redox.2023.102754_bib201","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-017-0914-5","article-title":"Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression","volume":"34","author":"Ma-On","year":"2017","journal-title":"Med. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib202","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-018-0669-8","article-title":"Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78","volume":"9","author":"Cai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2023.102754_bib203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2012.12.014","article-title":"Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance","volume":"57","author":"Niture","year":"2013","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101131","article-title":"Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway","volume":"22","author":"Zhou","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib205","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopha.2018.04.105","article-title":"The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells","volume":"103","author":"Pirpour Tazehkand","year":"2018","journal-title":"Biomed. Pharmacother. Biomed. pharmacotherapie"},{"key":"10.1016\/j.redox.2023.102754_bib206","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.urolonc.2014.02.006","article-title":"The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer","volume":"32","author":"Hayden","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib207","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.02.021","article-title":"Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism","volume":"150","author":"Cucci","year":"2020","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib208","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1182\/blood-2012-04-422121","article-title":"The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance","volume":"120","author":"Rushworth","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.redox.2023.102754_bib209","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2017.09.008","article-title":"iASPP is an antioxidative factor and drives cancer growth and drug resistance by competing with Nrf2 for Keap 1 binding","volume":"32","author":"Ge","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2023.102754_bib210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","article-title":"Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis","volume":"11","author":"Roh","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib211","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00280-016-3225-1","article-title":"The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy","volume":"79","author":"Chen","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib212","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-18-3668","article-title":"Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer","volume":"79","author":"Srivastava","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib213","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1038\/cddis.2013.337","article-title":"Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies","volume":"4","author":"Fan","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2023.102754_bib214","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer stem cells: the architects of the tumor ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.redox.2023.102754_bib215","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.molcel.2019.03.002","article-title":"DNA damage signaling-induced cancer cell reprogramming as a driver of tumor relapse","volume":"74","author":"Filipponi","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2023.102754_bib216","article-title":"Cancer cells change their glucose metabolism to overcome increased ROS: one step from cancer cell to cancer stem cell?","volume":"112","author":"Ghanbari Movahed","year":"2019","journal-title":"Biomed. Pharmacother. Biomed. pharmacotherapie"},{"key":"10.1016\/j.redox.2023.102754_bib217","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"16","author":"Lee","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.redox.2023.102754_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151073","article-title":"ROS and oncogenesis with special reference to EMT and stemness","volume":"99","author":"Chatterjee","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.redox.2023.102754_bib219","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-18-2558","article-title":"Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells","volume":"79","author":"Park","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ccr.2013.02.021","article-title":"ROS links glucose metabolism to breast cancer stem cell and EMT phenotype","volume":"23","author":"Schieber","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2023.102754_bib221","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature07733","article-title":"Association of reactive oxygen species levels and radioresistance in cancer stem cells","volume":"458","author":"Diehn","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.redox.2023.102754_bib222","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.redox.2023.102754_bib223","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23010084","article-title":"ROS modulator molecules with therapeutic potential in cancers treatments","volume":"23","author":"Nicco","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2023.102754_bib224","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib225","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive oxygen species (ROS)-Based nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.redox.2023.102754_bib226","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104641","article-title":"Sono-controllable and ROS-sensitive CRISPR-cas9 genome editing for augmented\/synergistic ultrasound tumor nanotherapy","volume":"33","author":"Pu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2023.102754_bib227","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1pd-L1 for enhanced cancer immunotherapy","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2023.102754_bib228","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drup.2016.10.003","article-title":"New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy","volume":"29","author":"Gabizon","year":"2016","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anti Cancer Chemother."},{"key":"10.1016\/j.redox.2023.102754_bib229","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.bmc.2015.05.006","article-title":"Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis","volume":"23","author":"Akladios","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib230","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802244","article-title":"Emerging strategies of nanomaterial-mediated tumor radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2023.102754_bib231","article-title":"In response to precision medicine: current subcellular targeting strategies for cancer therapy","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2023.102754_bib232","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/ijo.2016.146","article-title":"Mitochondria-targeted dodecyltriphenylphosphonium (C(12)TPP) combats high-fat-diet-induced obesity in mice","volume":"40","author":"Kalinovich","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.redox.2023.102754_bib233","article-title":"Inhibition of mitochondrial biosynthesis using a \"Right-Side-Out\" membrane camouflaged micelle to facilitate the therapeutic effects of shikonin on triple-negative breast cancer","author":"Peng","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.redox.2023.102754_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.875818","article-title":"Mitochondria-targeted mesoporous organic silica nanoplatforms for overcoming cisplatin resistance by disturbing mitochondrial redox homeostasis","volume":"10","author":"Lv","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.redox.2023.102754_bib235","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2023.102754_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1007","article-title":"Endoplasmic reticulum stress in the development of multiple myeloma and drug resistance","volume":"7","author":"Nikesitch","year":"2018","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.redox.2023.102754_bib237","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","article-title":"Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","volume":"17","author":"Oriol","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib238","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm. : Off. J. Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.redox.2023.102754_bib239","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1476-5381.2010.01064.x","article-title":"The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?","volume":"162","author":"McLaughlin","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2013.08.003","article-title":"The role of heat shock proteins in Amyotrophic Lateral Sclerosis: the therapeutic potential of Arimoclomol","volume":"141","author":"Kalmar","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.redox.2023.102754_bib241","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8336","article-title":"Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma","volume":"48","author":"Deng","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib242","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117103","article-title":"Drug delivery systems based on CD44-targeted glycosaminoglycans for cancer therapy","volume":"251","author":"Li","year":"2021","journal-title":"Carbohydrate Polym."},{"key":"10.1016\/j.redox.2023.102754_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117187","article-title":"Chondroitin sulfate-hybridized zein nanoparticles for tumor-targeted delivery of docetaxel","volume":"253","author":"Lee","year":"2021","journal-title":"Carbohydrate Polym."},{"key":"10.1016\/j.redox.2023.102754_bib245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.carbpol.2019.02.084","article-title":"Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles","volume":"213","author":"Liu","year":"2019","journal-title":"Carbohydrate Polym."},{"key":"10.1016\/j.redox.2023.102754_bib246","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jare.2021.07.010","article-title":"A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy","volume":"34","author":"Mu","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.redox.2023.102754_bib247","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101665","article-title":"Targeting the transferrin receptor for brain drug delivery","volume":"181","author":"Johnsen","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.redox.2023.102754_bib248","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/IJN.S149458","article-title":"Bioreducible nanocapsules for folic acid-assisted targeting and effective tumor-specific chemotherapy","volume":"13","author":"Yi","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.redox.2023.102754_bib249","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.apsb.2018.05.010","article-title":"Understanding the biology of HER3 receptor as a therapeutic target in human cancer","volume":"8","author":"Lyu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.redox.2023.102754_bib251","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.freeradbiomed.2020.07.032","article-title":"The novel SOD mimetic GC4419 increases cancer cell killing with sensitization to ionizing radiation while protecting normal cells","volume":"160","author":"El-Mahdy","year":"2020","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib252","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.redox.2018.09.020","article-title":"Persistent increase in mitochondrial superoxide mediates cisplatin-induced chronic kidney disease","volume":"20","author":"Mapuskar","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib253","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112198","article-title":"MnTnHex-2-PyP(5+) displays anticancer properties and enhances cisplatin effects in non-small cell lung cancer cells","volume":"11","author":"Soares","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102754_bib254","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111769","article-title":"MnTnHex-2-PyP(5+), coupled to radiation, suppresses metastasis of 4T1 and MDA-MB-231 breast cancer via AKT\/snail\/EMT pathways","volume":"10","author":"Shin","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102754_bib255","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1200\/JCO.19.01507","article-title":"Phase IIb, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer","volume":"37","author":"Anderson","year":"2019","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.redox.2023.102754_bib256","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1007\/s11033-014-3417-x","article-title":"Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways","volume":"41","author":"Azad","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.redox.2023.102754_bib257","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2021.09.017","article-title":"Radioresistance and transcriptional reprograming of invasive glioblastoma cells","volume":"112","author":"Tang","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.redox.2023.102754_bib258","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15252\/emmm.201606230","article-title":"Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy","volume":"9","author":"Benkafadar","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2023.102754_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101804","article-title":"Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy","volume":"38","author":"Cushing","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102754_bib260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O(2)(\u22c5-) and H(2)O(2)-mediated disruption of Fe metabolism causes the differential susceptibility of NSCLC and GBM cancer cells to pharmacological ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2023.102754_bib261","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-18-1680","article-title":"Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer","volume":"78","author":"Alexander","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib262","doi-asserted-by":"crossref","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2023.102754_bib263","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.redox.2023.102754_bib264","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/1078-0432.CCR-19-0594","article-title":"First-in-Human phase I clinical trial of pharmacologic ascorbate combined with radiation and temozolomide for newly diagnosed glioblastoma","volume":"25","author":"Allen","year":"2019","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.redox.2023.102754_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102318","article-title":"Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer","volume":"53","author":"Furqan","year":"2022","journal-title":"Redox Biol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:32:07Z","timestamp":1761978727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":265,"alternative-id":["S2213231723001556"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102754","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced oxidative stress in cancer treatments: Angel or devil?","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102754"}}